Flixabi 100 mg
Flixabi 100 mg is a medicine authorised by Swissmedic under authorisation number 70087. The authorisation holder is Samsung Bioepis CH GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 November 2025 and the authorisation is limited until 05 November 2030. ATC code L04AB02 places the medicine in the group Immunosuppressants.
| Authorisation number | 70087 |
|---|---|
| Name | Flixabi 100 mg |
| Full name | Flixabi 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Samsung Bioepis CH GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AB02 |
| First authorisation | 06 November 2025 |
| Authorisation validity | 05 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Flixabi 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 06 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AB02 | 07.15.0. | A |
| 2 | 3 | Durchstechflasche(n) | L04AB02 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Flixabi 100 mg authorised in Switzerland?
Yes. Flixabi 100 mg is authorised by Swissmedic under authorisation number 70087, data as of 01 September 2026. The authorisation is limited until 05 November 2030.
Which dispensing category does Flixabi 100 mg have?
Flixabi 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Flixabi 100 mg?
The authorisation holder is Samsung Bioepis CH GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.